Skip to main content
TipRanks
Go Ultimate75% OFF

Idexx Laboratories (IDXX) Operating Income by Segment

2,182 Followers

Operating Income by Segment

Idexx Laboratories reported operating income by segment of $261.69M in Q4 2024, down 13.9% from Q3 2024 and up 6.7% year over year. The highest value was $303.89M in Q3 2024.

Shows operating profit and margins for each segment, indicating where Idexx is most efficient and where higher R&D, sales or admin costs are weighing on returns. Helps spot which businesses are contributing real profits versus those that may require heavy investment to scale.

-$50.00M$0.00$50.00M$100.00M$150.00M$200.00M$250.00M$300.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24
Chart Insights

IDEXX Laboratories' CAG segment shows consistent growth, reflecting strong execution and innovation adoption, as highlighted by recent earnings. Despite fluctuations in other segments, CAG's robust performance aligns with a 7.5% increase in diagnostic recurring revenues and record instrument placements. However, challenges like declining U.S. clinical visits and Rapid assay revenue dips could impact future growth. The company's optimistic outlook, with increased revenue and EPS projections, underscores confidence in overcoming these hurdles and sustaining momentum, particularly in international markets where growth remains strong.

No longer reported by the company (last reported Q4 2024)

IDXX Operating Income by Segment

PeriodOtherCAGWaterLPDTotal
Q4 2024Dec 31, 2024-$2.77M$240.09M$20.99M$3.38M$261.69M
Q3 2024Sep 30, 2024$2.31M$277.08M$23.61M$889.00K$303.89M
Q2 2024Jun 30, 2024$248.00K$241.55M$20.50M$1.50M$263.80M
Q1 2024Mar 31, 2024-$1.03M$279.70M$19.43M$866.00K$298.96M
Q4 2023Dec 31, 2023$1.65M$222.12M$17.22M$4.31M$245.30M
Q3 2023Sep 30, 2023-$808.00K$253.36M$20.33M$2.40M$275.28M
Q2 2023Jun 30, 2023-$1.14M$275.51M$19.82M$1.95M$296.14M
Q1 2023Mar 31, 2023$370.00K$261.75M$16.97M$1.31M$280.40M
Q4 2022Dec 31, 2022$3.30M$199.84M$18.02M$5.36M$226.53M
Q3 2022Sep 30, 2022-$1.03M$221.45M$19.92M$4.48M$244.83M
Q2 2022Jun 30, 2022$1.39M$156.53M$17.92M$3.23M$179.07M
Q1 2022Mar 31, 2022$1.83M$223.13M$16.65M$6.74M$248.34M
Q4 2021Dec 31, 2021$4.86M$174.13M$15.85M$4.36M$199.19M
Q3 2021Sep 30, 2021$2.82M$201.95M$17.60M$3.60M$225.96M
Q2 2021Jun 30, 2021$422.00K$234.74M$17.23M$6.87M$259.25M
Q1 2021Mar 31, 2021$5.83M$213.21M$14.77M$13.81M$247.62M
Q4 2020Dec 31, 2020$9.20M$148.82M$15.48M$11.59M$185.09M
Q3 2020Sep 30, 2020$6.67M$139.43M$15.24M$10.51M$171.86M
Q2 2020Jun 30, 2020$4.77M$167.97M$12.26M$8.25M$193.25M
Q1 2020Mar 31, 2020$121.00K$118.66M$15.88M$9.66M$144.32M

Related KPIs